Arch Biopartners Inc. ( ACHFF) - Key Metrics
ACHFF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2026Q2 | $0 | -$0.01 | $0 | $0 |
| 2026Q1 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2025Q4 | $0 | $0 | $0 | $0 |
| 2025Q3 | $0 | $0 | $0 | $0 |
ACHFF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -29.02 |
| 2026Q2 | 0% | -14.68 |
| 2026Q1 | 0% | -12.84 |
| 2025Q4 | 0% | -78.46 |
| 2025Q3 | 0% | -119.47 |
ACHFF
Price: $0.61
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -29.15
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 38.8 million